Futura Medical (LON:FUM) Stock Price Up 5% – What’s Next?

Futura Medical plc (LON:FUMGet Free Report)’s share price rose 5% during mid-day trading on Friday . The company traded as high as GBX 0.50 and last traded at GBX 0.44. Approximately 2,716,760 shares were traded during trading, a decline of 71% from the average daily volume of 9,240,644 shares. The stock had previously closed at GBX 0.42.

Futura Medical Trading Up 5.0%

The firm has a market capitalization of £2.56 million, a PE ratio of -0.16 and a beta of 0.02. The business’s 50 day simple moving average is GBX 0.45 and its 200 day simple moving average is GBX 0.84.

About Futura Medical

(Get Free Report)

Futura Medical plc (AIM: FUM) is the developer of innovative sexual health products, including lead product Eroxon® and products WSD4000 and Eroxon® Intense. Our core strength lies in our research, development and commercialisation of topically delivered gel formulations in sexual health products.

Sexual health issues are prevalent in both men and women. ED impacts 1 in 5 men globally across all adult age brackets, with approximately half of all men over 40 experiencing ED and 25% of all new diagnoses being in men under 40.

Read More

Receive News & Ratings for Futura Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Futura Medical and related companies with MarketBeat.com's FREE daily email newsletter.